Evidence map›Paper›PMID 26826734›Full record

ArticleBioorganic & medicinal chemistry letters2016

Computer-aided design of negative allosteric modulators of metabotropic glutamate receptor 5 (mGluR5): Comparative molecular field analysis of aryl ether derivatives.

Chelliah Selvam, Ramasamy Thilagavathi, Balasubramanian Narasimhan, Pradeep Kumar, Brian C Jordan, Kasturi Ranganna

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chelliah SelvamDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA. Electronic address: chelliahs@tsu.edu.
Ramasamy ThilagavathiDepartment of Biotechnology, Faculty of Engineering, Karpagam Academy of Higher Education, Coimbatore, India. Electronic address: thilagavathir@yahoo.com.
Balasubramanian NarasimhanDepartment of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India.
Pradeep KumarCentre for Pharmaceutical Sciences and Natural Products, School of Basic and Applied Sciences, Central University of Punjab, Bathinda, India.
Brian C JordanDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA.
Kasturi RangannaDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA.

Funding

Center for Biomedical and Health Research Excellence (CBHRE)G12MD007605 · NIMHD · TEXAS SOUTHERN UNIVERSITY · PI OYEKAN, ADEBAYO O., WILSON, BOBBY L · 2014 to 2018
$7.1M
NIMHD NIH HHS 2G12MD007605NIMHD NIH HHS G12 MD007605
6 · The paper itself

Abstract

The metabotropic glutamate receptors (mGlu receptors) have emerged as attractive targets for number of neurological and psychiatric disorders. Recently, mGluR5 negative allosteric modulators (NAMs) have gained considerable attention in pharmacological research. Comparative molecular field analysis (CoMFA) was performed on 73 analogs of aryl ether which were reported as mGluR5 NAMs. The study produced a statistically significant model with high correlation coefficient and good predictive abilities.

Indexed as

Allosteric RegulationComputer-Aided DesignEthersInhibitory Concentration 50Molecular ConformationProtein BindingQuantitative Structure-Activity RelationshipReceptor, Metabotropic Glutamate 5EthersReceptor, Metabotropic Glutamate 53-D QSARAryl ethersCoMFAmGluR5Negative allosteric modulators

Identifiers

PMID26826734
PMCPMC4836281

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.